Wuhan Keqian Biology Co Ltd (688526) — Cash Flow Reinvestment Rate
Wuhan Keqian Biology Co Ltd (688526) has a Cash Flow Reinvestment Rate of 0.07x as of September 2025, reinvesting CN¥11.35 Million (capex CN¥11.35 Million ) from operating cash flow of CN¥174.36 Million. See Wuhan Keqian Biology Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wuhan Keqian Biology Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Wuhan Keqian Biology Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see Wuhan Keqian Biology Co Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Wuhan Keqian Biology Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Wuhan Keqian Biology Co Ltd. See 688526 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.78x | CN¥307.88 Million | CN¥392.68 Million | CN¥106.94 Million | ▼ -2.7% |
| 2023 | 0.81x | CN¥433.50 Million | CN¥538.03 Million | CN¥104.50 Million | ▼ -53.9% |
| 2022 | 1.75x | CN¥739.98 Million | CN¥423.71 Million | CN¥102.85 Million | ▲ +31.5% |
| 2021 | 1.33x | CN¥705.55 Million | CN¥531.27 Million | CN¥374.45 Million | ▼ -59.2% |
| 2020 | 3.25x | CN¥1.30 Billion | CN¥400.14 Million | CN¥111.60 Million | ▼ -33.8% |
| 2019 | 4.92x | CN¥761.46 Million | CN¥154.89 Million | CN¥137.74 Million | ▲ +5404.8% |
| 2018 | 0.09x | CN¥31.42 Million | CN¥351.83 Million | CN¥31.42 Million | ▼ -76.6% |
| 2017 | 0.38x | CN¥129.11 Million | CN¥337.61 Million | CN¥129.11 Million | ▲ +189.7% |
| 2016 | 0.13x | CN¥29.13 Million | CN¥220.69 Million | CN¥29.13 Million | — |